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1 Instructions to the authors 
 
ISBER welcomes the submission of abstracts in fields related to the use of environmental and 
biological repositories. Special consideration will be given to those abstracts that focus on challenges 
in the area of biorepositories and solutions to those problems. Abstracts should contain significant or 
novel scientific information. Product advertisements are not appropriate for presentation. ISBER 
reserves the right to exclude abstracts that promote commercial interests inappropriately or are 
viewed as unethical in content. Submitted abstracts will be evaluated anonymously by a review 
panel, and accepted based on scientific merit and contribution to their area of science. Accepted 
abstracts will be published on the ISBER web site and in their entirety in the Spring 2010 issue of 
Biopreservation and Biobanking (BIO) (formerly Cell Preservation Technology), the official journal of 
ISBER. Withdrawn abstracts may not be published in BIO. 
 
Topic Categories Include:
•  Environmental Repositories 
•  “Green” Repository Solutions 
 
•  Animal Specimen Repositories 
•  Biospecimen Science 
•  Cryogenics and Cell Preservation 
•  Disaster Recovery 
•  Human Specimen Repositories 
•  Legal and Ethical Issues Related to Repositories 
•  Museum Repositories, 
•  National and International Biobanking Networks  
•  Other Hot Topics,  
•  Plant/Seed Repositories, 
•  Quality Assurance and Control  
•  Repository Automation  
•  Repository Information Technologies  
Submit your abstract online at www.isber.org/mtgs/2010Rotterdam/abstracts.html 
 
PRESENTATION FORMAT 
 
Authors should indicate their preference for presentation (poster vs. oral presentations).  The 
Program Committee will attempt to honor the authors' preference but the final format decision will 
be based on the overall constraints of the scientific program. 
 
No Preference - The authors do not have a preference for oral presentation, poster plus lightning 
round oral presentation, or poster presentation and agree to present their data in the format chosen 
by the Program Committee. 
Poster Presentation - Posters will be displayed for one or two days as determined by the Program 
Committee. 
Poster Plus Lightning Round Oral Presentation - In addition to presenting a poster, the author will be 
asked to ALSO highlight the abstract in a 5 minute oral presentation.  
Oral Presentation – Authors selected to present in a Contributed Papers Session will be allotted 15 
minutes to present the abstract.  Abstracts selected for a Contributed Paper Session will NOT present 
a poster. 
 
ISBER RULES FOR ABSTRACT SUBMISSION 
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1. Product advertisements are not appropriate for presentation. ISBER reserves the right to 
exclude abstracts that promote commercial interests inappropriately or are viewed as 
unethical in content.  
2. Complete abstracts must be submitted online no later than 11:59PM Eastern Time on Friday, 
January 29, 2010. No changes can be made to abstract content or authors after the 
submission deadline.  
3. All abstracts must be submitted online. Faxed, emailed or mailed abstracts are not 
acceptable.  
4. Each author may submit a maximum of two abstracts as first author and may be included as 
coauthor on up to five additional abstracts.  
5. Once an abstract is accepted, additional authors cannot be added.  
6. The Presenting Author should be the primary contact (or Corresponding Author)  
7. Notification of acceptance or rejection and all future correspondence will be mailed to the 
presenter from the ISBER office by March 1, 2010.  
8. ISBER reserves the right to withdraw a presentation at any time.  
9. Accepted abstracts that report information that has not been previously published will be 
published in the Official Journal of ISBER Biopreservation and Biobanking
10. All accepted abstracts will be published in the program book.  
.  
11. The Presenting Author is expected to register for the ISBER Meeting and present the abstract 
at the assigned time period to discuss the study and answer questions. If the Presenting 
Author is unable to attend the ISBER Meeting to present the abstract, every effort should be 
made to arrange for one of the other authors to present the poster. Both ISBER staff 
(shamilton@asip.org) and the ISBER Meeting Program Chair, Scott Jewell 
(Scott.Jewell@osumc.edu) must be notified of any change in presenters.  
1. Language: The abstract must be written in English.  
ABSTRACT FORMATTING INSTRUCTIONS 
2. Topic Selection: To ensure that your abstract is reviewed for the appropriate session, click a 
choice from the "Categories List."  
3. Presentation Format: At the meeting your paper may be presented orally or as a poster. 
Please indicate your preference. Space for oral presentations may be limited and therefore 
the Program Committee may need to override your preference.  
4. Title: Title must be initial caps throughout. Example: Human Repositories and Specimen 
Collection in China  
5. Abstract: Abstracts must be 250 words or less and should be organized into four sections as 
outlined below. Wherever possible, start each section of the abstract with the heading 
Background, Methods, Results, and Conclusions. Figures and tables are NOT permitted in the 
abstract.  
6. Confirmation: When you finish submitting your abstract, you will receive a confirmation 
screen verifying your submission and assigning a tracking number to your abstract. SAVE 
YOUR TRACKING NUMBER! It will serve as your identification number for corrections, 
scheduling, and notification.  
7. Corrections: If you have changes to your abstract please log in as a returning user with your 
email address and password. You will be able to edit your submitted abstracts (until January 
29, 2010) by clicking on the ID number of the abstract you wish to edit. DO NOT CREATE A 
NEW SUBMISSION. 
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2 Abstracts 
2.1 ISBER 2010 – abstract “Swiss Biobank Survey” 
Survey of Biobanks at a Swiss University Hospital 
Currat-Zweifel C1, Leyvraz S1, Simeon-Dubach D2, Horisberger J-D3†, Stamenkovic I4
 
,  
1Biobanque de Lausanne, Fondation du Centre Pluridisciplinaire d’Oncologie, CHUV, Lausanne, Switzerland, 
2Foundation biobank-suisse, Bern, Switzerland, 3Institut de Pharmacologie et de Toxicologie, CHUV, Lausanne, 
Switzerland, 4
 
Institut de Pathologie, CHUV, Lausanne, Switzerland 
Human biobanks are a valuable source of biospecimens and personal data to be used for research. 
Little is known of how many biobanks exist at a given Swiss University Hospital.  
The purpose of this survey conducted at the CHUV hospital ( >40’000 patients hospitalized per year) 
and the faculty of biology and medicine (FBM) at the University in Lausanne, Switzerland was a) to 
provide an overview of the number of biobanks, b) to assess their purpose and size, c) to determine 
the kinds of biospecimens collected and d) to analyse the extent to which the biobanks follow the 
Swiss Academy of Medical Sciences (SAMS) guidelines on biobanks. 
Eighty-three services (FBM: 15, CHUV: 68) were contacted. Twenty did not respond, 35 had no 
collection of human biospecimens. 28 services had 37 research biobanks and 6 collections for 
diagnosis and treatment; the latter were excluded from further analysis. Fifty-seven % of biobanks 
store > 1’000 biospecimens. One third of biobanks stored tissue (92% fresh frozen, 46% FFPE, 31% 
DNA, 23% RNA, and 23% frozen cells), 65% stored blood components (58% serum, 63% plasma, 46% 
frozen cells, 38% DNA, 17% RNA, and 4% whole blood). The majority of biobanks have accepted the 
SAMS guidelines. Forty-one % of biobanks used the biospecimens and data only for their own 
research, almost half share biospecimens and data, but only a quarter use a material transfer 
agreement.  
The data collected in this survey will allow biobank infrastructure optimization at the CHUV and will 
improve research support.  
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